Kala Bio CEO Avraham Minkowitz Files Form 3

KALA BIO, Inc. filed an initial ownership report (Form 3) for Avraham Minkowitz, who is both a director and the Chief Executive Officer.

Rhea-AI Filing Summary

KALA BIO, Inc. filed an initial ownership report (Form 3) for Avraham Minkowitz, who is both a director and the Chief Executive Officer. As of the event date of 01/30/2026, the filing states that no securities are beneficially owned, including no derivative securities positions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Kala Bio (KALA) Form 3 for Avraham Minkowitz show?

The Form 3 for Kala Bio (KALA) shows that CEO and director Avraham Minkowitz reported no securities beneficially owned as of 01/30/2026. The filing also indicates no derivative securities or other ownership positions were disclosed at that time.

What is Avraham Minkowitz’s role at Kala Bio (KALA) in this Form 3?

In this Form 3, Avraham Minkowitz is identified as both a director and an officer of Kala Bio (KALA), serving as Chief Executive Officer. The filing confirms his insider status while noting he reported no beneficial ownership of the company’s securities.

Does the Kala Bio (KALA) Form 3 disclose any stock or option holdings?

The Kala Bio (KALA) Form 3 explicitly states that no securities are beneficially owned. Both the non-derivative and derivative securities tables show no reported holdings, meaning no common stock, options, warrants, or other derivative positions are listed for Avraham Minkowitz.

Are there any transactions reported in this Kala Bio (KALA) Form 3?

No transactions are reported in this Kala Bio (KALA) Form 3. The document functions as an initial ownership statement for Avraham Minkowitz, and it states that no securities, including derivative securities, are beneficially owned as of the event date.

Why is a Form 3 filed for Kala Bio (KALA) CEO Avraham Minkowitz?

Form 3 is filed to report initial beneficial ownership when someone becomes an insider. For Kala Bio (KALA), CEO and director Avraham Minkowitz filed this Form 3 to confirm his status while disclosing that he held no beneficial ownership of company securities on 01/30/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 04:15 PM EST Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Minkowitz Avraham

(Last) (First) (Middle)

1167 MASSACHUSETTS AVENUE

(Street)

ARLINGTON MA 02476

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/30/2026

3. Issuer Name and Ticker or Trading Symbol
KALA BIO, Inc. [ KALA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Avraham Minkowitz	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.